Drug Shortage Report for DYMISTA
Report ID | 107640 |
Drug Identification Number | 02432889 |
Brand name | DYMISTA |
Common or Proper name | FLUTICASONE PROPIONATE azelastine hydrochloride |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | FLUTICASONE PROPIONATE AZELASTINE HYDROCHLORIDE |
Strength(s) | 50MCG 137MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 25 ML |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-03-16 |
Actual start date | 2020-03-17 |
Estimated end date | 2020-03-23 |
Actual end date | 2020-03-25 |
Shortage status | Resolved |
Updated date | 2020-03-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-03-26 | English | Compare |
v7 | 2020-03-25 | French | Compare |
v6 | 2020-03-25 | English | Compare |
v5 | 2020-03-18 | French | Compare |
v4 | 2020-03-18 | English | Compare |
v3 | 2020-03-17 | English | Compare |
v2 | 2020-03-03 | French | Compare |
v1 | 2020-03-03 | English | Compare |
Showing 1 to 8 of 8